Pet dander and perennial allergic rhinitis: therapeutic options

Area of Science:

• Allergy and Immunology
• Environmental Health

Background:

• Pet allergy is a growing health concern, potentially the most common perennial allergen in the U.S.
• Increased pet ownership correlates with a rise in indoor pet allergen prevalence (90% of homes).
• Key allergens include Fel d 1 (cats) and Can f 1 (dogs), with five well-described allergens for each.

Purpose of the Study:

• To review the current landscape of pet allergy management.
• To discuss evidence-based environmental control strategies.
• To outline pharmacotherapy and allergen immunotherapy options.

Main Methods:

• Review of recent skin-prick testing data and epidemiological trends.
• Analysis of research on environmental allergen reduction.
• Evaluation of pharmacotherapy and immunotherapy for allergic rhinitis.

Main Results:

• Pet allergens are ubiquitous in homes and public indoor spaces.
• Environmental modifications show more impact on allergen reduction than symptom relief.
• Pharmacotherapy choice depends on rhinitis type (episodic vs. perennial) and symptom severity.

Conclusions:

• Given low pet relinquishment rates, evidence-based environmental control is crucial.
• A stepwise approach to pharmacotherapy, including combination therapy, is proposed.
• Allergen immunotherapy is the only disease-modifying treatment and recommended for moderate-to-severe pet-induced perennial allergic rhinitis (PAR).